![White car (Porsche Taycan) with the hood popped is inside the building with an american flag on the wall.](/sites/default/files/styles/featured_square_large/public/2024-06/2024-P09317.jpg?h=8f9cfe54&itok=m6sQhZRq)
Filter News
Area of Research
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (16)
- Clean Energy (22)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (5)
- Fusion Energy (5)
- Isotopes (11)
- Materials (11)
- Materials for Computing (1)
- National Security (2)
- Neutron Science (6)
- Nuclear Science and Technology (10)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (10)
News Topics
- (-) Bioenergy (22)
- (-) Biomedical (15)
- (-) Exascale Computing (4)
- (-) Grid (16)
- (-) Isotopes (13)
- (-) Net Zero (1)
- (-) Nuclear Energy (23)
- 3-D Printing/Advanced Manufacturing (41)
- Advanced Reactors (9)
- Artificial Intelligence (19)
- Big Data (12)
- Biology (23)
- Biotechnology (6)
- Buildings (13)
- Chemical Sciences (7)
- Clean Water (13)
- Climate Change (11)
- Composites (8)
- Computer Science (65)
- Coronavirus (10)
- Critical Materials (4)
- Cybersecurity (10)
- Decarbonization (7)
- Energy Storage (30)
- Environment (58)
- Frontier (6)
- Fusion (13)
- High-Performance Computing (19)
- ITER (4)
- Machine Learning (6)
- Materials (32)
- Materials Science (42)
- Mathematics (1)
- Mercury (4)
- Microscopy (15)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (7)
- Neutron Science (36)
- Physics (9)
- Polymers (7)
- Quantum Computing (5)
- Quantum Science (22)
- Security (5)
- Space Exploration (8)
- Statistics (1)
- Summit (18)
- Sustainable Energy (43)
- Transportation (33)
Media Contacts
![Vittorio Badalassi, left, of Oak Ridge National Laboratory leads the Fusion Energy Reactor Models Integrator, or FERMI, project, and collaborates with ORNL computational physicist David Green. FERMI applies fission platforms to fusion reactor design. Credit: Commonwealth Fusion Systems and Colby Earles/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/FERMI_v3_web_art_for_landing_page_carousel_2021_04_20_1.jpg?h=d1cb525d&itok=y2KEq11p)
Oak Ridge National Laboratory expertise in fission and fusion has come together to form a new collaboration, the Fusion Energy Reactor Models Integrator, or FERMI
![Brenda Smith, shown here working with a gas viscometer in her research lab, is one of several people concurrently researching the thermophysical properties of feedstock gas. Their research will support computational researchers who are designing processes to separate isotopes. Credit: Carlos Jones/ORNL, US Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-05/2021-P01103_0.jpg?h=13f436e5&itok=lMLI1EqU)
For years Brenda Smith found fulfillment working with nuclear batteries, a topic she’s been researching as a chemist at Oak Ridge National Laboratory.
![Scientists genetically engineered bacteria for itaconic acid production, creating dynamic controls that separate microbial growth and production phases for increased efficiency and acid yield. Credit: NREL](/sites/default/files/styles/list_page_thumbnail/public/2021-05/Putida_forAdam_2clr_2.jpg?h=71f44bf2&itok=8u0ZVufx)
A research team led by Oak Ridge National Laboratory bioengineered a microbe to efficiently turn waste into itaconic acid, an industrial chemical used in plastics and paints.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![ORNL ecosystem scientist Colleen Iversen talked to fourth-grade students at Coulter Grove Intermediate School in Maryville on Friday, April 23, as part of National Environmental Education Week.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/Sciencetalk3_1.jpg?h=29234840&itok=wWaAJG05)
Esther Parish is one of eight scientists from the Department of Energy's Oak Ridge National Laboratory talking to students in nine schools across East Tennessee as part of National Environmental Education Week, or EE Week.
![Nuclear engineer Nesrin Ozgan Cetiner led ORNL’s collaboration with AMS Corp. to test instrument and control sensors for the next generation of nuclear power reactor technology. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/Nesrin_Cetiner_AMS_article_2021-P02224%5B2%5D.jpg?h=acaf5000&itok=YDUKbigy)
Toward the goal of bringing the next generation of nuclear power reactor technology online this decade, ORNL and Analysis and Measurement Services Corporation have successfully completed loop testing of instrument and control sensors for an advanced reactor design for small modular reactors.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.